UOB prices $796.76m bonds at 0.25%

They are expected to be issued by 11 September.

UOB issued its $796.76m (€500m) covered bonds due 2023 at 0.25%. They will be the sixth series under the US$8b global covered bond programme of the bank.

The bank will be joined by HSBC France, Norddeutsche Landesbank – Girozentrale, Société Générale, and UBS Limited as lead managers for the covered bonds.

According to an announcement, said bonds will be guaranteed as to payments of interest and principal by Singapore finance firm Glacier Eighty (CBG). 

“The guarantee is secured by a portfolio of loans purchased by the CBG from the Company and other assets of the CBG Ratings,” UOB explained.

Eyed for issuance on 11 September, the covered bonds are expected to be rated Aaa by Moody’s Investors Service and AAA by Standard & Poor's Rating Services.

They will also file an application to the Singapore Exchange Securities Trading(the (SGX-ST) for the listing and quotation of the bonds.

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare